| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
germinal center associated signaling and motility like | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||||
|
transmembrane and coiled-coil domain family 2 | 0.29 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
interferon regulatory factor 1 | 0.468 | 0.769 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
mitofusin 2 | 0.471 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2018 | ||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
jumonji domain containing 1C | 0.517 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
myocyte enhancer factor 2C | 0.517 | 0.769 | 1.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
plectin | 0.523 | 0.808 | 8.3E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2016 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2018 | ||||||||
|
ARVCF delta catenin family member | 0.540 | 0.769 | 5.0E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
flap structure-specific endonuclease 1 | 0.550 | 0.731 | 4.8E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2019 | ||||||||
|
RAD51 paralog B | 0.556 | 0.769 | 2.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
zinc finger protein, FOG family member 2 | 0.565 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2016 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2018 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2018 | ||||||||
|
cholinergic receptor nicotinic epsilon subunit | 0.636 | 0.577 | 4.7E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
microtubule affinity regulating kinase 4 | 0.641 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2016 |